ML2006a4, an orally active SARS-CoV-2 main protease (Mpro) inhibitor, exhibits potent activity with an IC50 in the picomolar range. This compound is cell permeable and demonstrates antiviral efficacy by inhibiting the replication of SARS-CoV-2 in Huh7.5.1-ACE2-TMPRSS2 (Huh7.5.1++) cells at picomolar concentrations [1].
Molecular Weight:
627.7
CAS Number:
[2943213-62-3]
Formula:
C30H44F3N5O6
Target:
SARS-CoV
T86909
* VAT and and shipping costs not included. Errors and price changes excepted